![]()
MIRA INFORM REPORT
|
Report Date : |
14.04.2011 |
IDENTIFICATION DETAILS
|
Name : |
NAWAKRAMA (PVT) LTD |
|
|
|
|
Registered Office : |
No. 35/1/1,
Devanampiyatissa Mawatha, Colombo-10 |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
10.01.1986 |
|
|
|
|
Com. Reg. No.: |
N (PVS) 2341 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Importers and Distributors of Pharmaceuticals,
surgical & medical diagnostics |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
|
|
Status : |
Moderate |
|
Payment
Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Name : Mr. Jayantha
Dharmadasa
Designation : Chairman
Date : 13.04.2011
|
Name of Subject of
Inquiry |
: |
NAWAKRAMA (PVT) LTD |
|
Legal Form
& Status |
: |
Private
Limited Liability Company (In
operation) |
|
Chairman
|
: |
Jayantha
Dharmadasa |
|
Primary Line of
Business |
: |
Importers and Distributors of
Pharmaceuticals, surgical & medical
diagnostics. |
|
Head Office & Place of Business |
: |
Peliyagoda, Tel. No: (00 94 11) 534 4444 / 291 3911 Fax No: (00 94 11) 534 4400 / 291 3910 E-mail: pharma@nawakrama.com; nawak@slt.lk
|
|
No. of Employees |
: |
Approximately 200 |
|
Registration No |
: |
N (PVS) 2341 |
||
|
Date of Registration |
|
10th
January 1986 |
||
|
Re-registration No |
: |
PV 1145 |
||
|
Date of Re-registration |
|
27th November
2007 |
||
|
Registered Office |
: |
No. 35/1/1, Devanampiyatissa
Mawatha, Colombo-10, |
||
|
Board Of Directors As At 10th October, 2010 |
: |
Jayantha
Dharmadasa |
Chairman
|
|
|
U. H. Dharmadasa |
CEO/Director |
|||
|
C. S. Dharmadasa |
Director |
|||
|
Issued Share Capital |
: |
Rs.
25,000,000.00 |
||
|
Nominal Value of Share |
: |
Rs. 10.00 |
||
|
Share Holders As At 10th October, 2010 |
: |
Share Holders |
No of Shears |
|
|
Jayantha
Dharmadasa |
1,500,000 |
|||
|
Chamitha Sreeni Dharmadasa |
500,000 |
|||
|
Ugitha Harshith Dharmadasa |
500,000 |
|||
Secretaries
|
:
|
Consultants
& Corporate Secretaries (Pvt) Ltd |
||
|
Auditors |
: |
Abeyrathne
& Company |
||
|
Bankers |
: |
Bank of Ceylon,
Hatton National Bank, Peoples Bank |
||
·
History.
The Subject Company NAWAKRAMA (PVT) LTD is a Private
Limited Liability Company incorporated on 10th January 1986 under registration number N (PVS) 2341
and has been re-registered in terms of Companies Act #7 of 2007 on 27th November 2007 under
registration number PV 1145.
Nawakrama (Pvt.)
Ltd is a leading and well established Pharmaceutical, Surgical and Laboratory
Diagnostic Equipment Company in
Nawakrama (Pvt) Ltd as a
leading international trading organization diversified into several fields of
business activities. It is also an associate company of the Nawaloka Group of
Companies which is having 18 Associate & Subsidiary companies. Nawakrama
(Pvt) Ltd established on 10th January 1986 by Mr. Jayantha Dharmadasa, one of the leading
businessmen in
1)
|
Name |
Jayantha
Dharmadasa |
|
Nationality |
Sri
Lankan |
|
ID
Number |
483122195
V |
|
Gender |
Male |
|
Date
of Birth |
7th
November 1948 |
|
Age |
62
Years |
|
Address
|
No.7,
|
2)
|
Name |
C.
S. Dharmadasa |
|
Nationality |
Sri
Lankan |
|
ID
Number |
545220016
V |
|
Gender |
Male |
|
Date
of Birth |
22nd
January 1954 |
|
Age |
56
Years |
|
Address
|
No.7,
|
3)
|
Name |
U.
H. Dharmadasa |
|
Nationality |
Sri
Lankan |
|
ID
Number |
741191415
V |
|
Gender |
Male |
|
Date
of Birth |
28th
April 1974 |
|
Age |
56
Years |
|
Address
|
No.7,
|
·
Subsidiary companies of Nawaloka Group
1.
Nawakrama
(Pvt) Ltd
2.
Nawaloka
Trading Co., Ltd
3.
Koala
Steel Fabrications
4.
Nawatex
(Private) Limited
5.
Koala
(Pvt) Ltd
The
Group’s business areas include construction, packaging, and also owns the largest private hospital namely “
Location.
The Subject Company is located at client given address No. 55,
·
Operations Details.
General
The subject company’s primary line of
business is Import and Distribution of
Pharmaceuticals and surgical products.
“Nawakrama”
distribution include pharmaceuticals, vaccines, diagnostics, medical equipment,
surgical products, hospital
equipment, dental products, construction equipment, welding equipment &
consumables, thermal & acoustic insulation material, cement admixtures,
hotel equipment, water treatment equipment and consumables
Products
Pharmaceuticals, Medical Equipment, Diagnostics, Vaccines, Surgical Products, Dental Products, Insulation Materials and Waterproofing Products.
Import Countries
No of Employees
Approximately 200
Companies Represented
·
Leben
Laboratories (Pvt) Ltd
·
Kilitch
Drugs
·
Lyka BDR
International
·
Medley
Pharmaceuticals –
·
Bharat
Serums & Vaccines Ltd
·
Tyco
Healthcare
·
Fresenius
Medical Care
·
Financial Data
The company has declined to provide
information on its finance.
In
publish their accounts for
public use, other than the Shareholders.
However, the company
claims that their annual turnover is around US$ 5 – 10 million.
·
Trade
references:
- Sri Lanka Chamber of the Pharmaceutical Industry.
·
Credit Recommendations
Since no financial information has been forthcoming from the company, it is not possible to comment on the merits or otherwise of the company.
No computerised data bases exist to make checks whether the partners or
the company has any legal action or lawsuit initiated against any of them but
informal (but not in-depth) checks do not indicate any such cases in the public
knowledge.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.48 |
|
|
1 |
Rs.72.37 |
|
Euro |
1 |
Rs.64.42 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.